Boehringer Ingelheim teams up with UICC for the second consecutive year for a special Facebook and Twitter Live World Cancer Day event.
This year’s discussion, taking place today on Friday 2 February at 3pm CET, puts rare cancers and its unmet treatment needs squarely in focus as the World Cancer Day weekend approaches.
A panel of experts in health and policy will convene in Frankfurt to drive greater understanding of the challenges in securing diagnosis and optimal treatment for rare cancers, including Mesothelioma, a cancer that is strongly linked with exposure to asbestos.
The panel will conclude with a discussion on the policies needed to address rare cancers along with an urgent call to policy makers to improve research funding, diagnosis, support and more affordable and equal access to treatment for patients living with mesothelioma and other rare cancers.
As part of today’s focus on mesothelioma, UICC has updated its call to action on asbestos and highlights the WHO top 10 chemicals of public health concern.
A recording of the Facebook Live event will be available this World Cancer Day, 4 February 2018.
About World Cancer Day
World Cancer Day takes place every year on 4 February and is the single initiative under which the world can unite to raise the profile of cancer in a positive and inspiring way. Spearheaded by the Union for International Cancer Control (UICC), World Cancer Day takes place for the last year under the tagline ‘We can. I can.’, which explores how everyone – as a collective or as individuals – can do their part to reduce the global burden of cancer. Just as cancer affects everyone in different ways, everyone has the power to take action to reduce the impact that cancer has. World Cancer Day is a chance to reflect on what you can do, make a pledge and take action.
For more information, please visit: www.worldcancerday.org